Table 3 Baseline-adjusted area under the concentrations versus time curve [AUC0–180 min] of plasma glucose, insulin and C-peptide after single oral intake of glucose or ENSO 16.

From: The substitute ENSO 16 has low impact on glucose metabolism in healthy humans: a randomized, double-blind, active-controlled, cross-over trial

 

Glucose

ENSO 16

p value

Glucose AUC0–180 min [mg*dL−1*min]

1258 ± 2002

− 85 ± 593

0.0128

Insulin AUC0–180 min [µIU*mL−1*min]

1509.70 ± 833.30

− 44.06 ± 325.60

 < 0.01

C-peptide AUC0–180 min [ng*dL−1*min]

252.30 ± 142.50

9.50 ± 27.70

 < 0.01

  1. Results are mean ± SD, n = 15 per treatment. Differences between treatments are indicated (Student’s paired t-test).
Back to article page